73 papers found
Refreshing results…
Changes in MIF and thyroxine, in a clinically relevant large animal model of sepsis
Increased asymmetrical dimethyl-arginine suppresses nitric oxide production in Pseudomonas aeruginosa sepsis
The selective V1areceptor agonist FE 202158 does not cause von Willebrand factor release in sheep unlike arginine vasopressin
The selective V1a receptor agonist FE 202158 does not cause von Willebrand factor release in sheep unlike arginine vasopressin
Increased asymmetrical dimethyl-arginine suppresses nitric oxide production in Pseudomonas aeruginosasepsis
Classroom Versus Computer-based CPR Training: A Comparison of the Effectiveness of Two Instructional Methods
Pathophysiologie des akuten Lungenversagens bei Schwerbrandverletzten mit Inhalationstrauma
Selective vs. Unselective V 1 -Receptor Agonism in Ovine Septic Shock.
Recombinant human activated protein C reduces cardiac 3-nitrotyrosine and malondialdehyde levels in ovine acute respiratory distress syndrome and septic shock
Arginine vasopressin increases plasma levels of von Willebrand factor in sheep
Effects of levosimendan on renal function in septic shock: a case–control study
Electron microscopic renal tubular injury score in ovine endotoxemia
Effects of levosimendan and inhaled nitric oxide on microcirculation in septic shock
Selective V1-agonism and selective V2-antagonism are superior to arginine vasopressin in ovine septic shock
Einfluß der Infusionstherapie auf die Apoptose im hämorrhagischen Schock in zentralen Schockorganen – eine kontrollierte experimentelle Studie am Schwein
RhAPC improves cerebral microcirculation in ovine acute lung injury and septic shock
Ceftazidime reduces cardiac 3-nitrotyrosine and malondialdehyde levels in ovine ards and septic shock
National Athletic Trainers' Association Position Statement: Acute Management of the Cervical Spine–Injured Athlete
Role of the Calcium Sensitizer, Levosimendan, in Perioperative Intensive Care Medicine
Das Sepsis-assoziierte Guillain-Barré-Syndrom
Missing publications? Read more about our data sources.